Biomea Fusion (BMEA) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

BMEA Stock Forecast

Biomea Fusion stock forecast is as follows: an average price target of $22.75 (represents a 256.58% upside from BMEA’s last price of $6.38) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

BMEA Price Target

The average price target for Biomea Fusion (BMEA) is $22.75 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $11.00. This represents a potential 256.58% upside from BMEA's last price of $6.38.

BMEA Analyst Ratings

Buy

According to 8 Wall Street analysts, Biomea Fusion's rating consensus is 'Buy'. The analyst rating breakdown for BMEA stock is 0 'Strong Buy' (0.00%), 7 'Buy' (87.50%), 1 'Hold' (12.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Biomea Fusion Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 31, 2024	Joseph Catanzaro	Piper Sandler	$19.00	$10.34	83.75%	197.81%
Oct 30, 2024	Peter Lawson	Barclays	$11.00	$12.06	-8.79%	72.41%
Oct 22, 2024	Joseph Pantginis	H.C. Wainwright	$40.00	$11.24	255.87%	526.96%
Sep 27, 2024	Joseph Catanzaro	Piper Sandler	$10.00	$9.90	1.01%	56.74%
Jun 07, 2024	Joseph Pantginis	H.C. Wainwright	$15.00	$4.24	253.78%	135.11%
Jun 07, 2024	George Farmer	Scotiabank	$21.00	$11.27	86.34%	229.15%
Jun 07, 2024	Peter Lawson	Barclays	$5.00	$11.27	-55.63%	-21.63%
Jun 14, 2022	Joseph Pantginis	H.C. Wainwright	$16.00	$8.50	88.22%	150.78%

Row per page

Go to

The latest Biomea Fusion stock forecast, released on Oct 31, 2024 by Joseph Catanzaro from Piper Sandler, set a price target of $19.00, which represents a 83.75% increase from the stock price at the time of the forecast ($10.34), and a 197.81% increase from BMEA last price ($6.38).

Biomea Fusion Price Target by Period

	1M	3M	12M
# Anlaysts	3	4	7
Avg Price Target	$23.33	$20.00	$17.29
Last Closing Price	$6.38	$6.38	$6.38
Upside/Downside	265.67%	213.48%	171.00%

In the current month, the average price target of Biomea Fusion stock is $23.33, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 265.67% increase as opposed to Biomea Fusion's last price of $6.38. This month's average price target is up 16.65% compared to last quarter, and up 34.93% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 31, 2024	Piper Sandler	Overweight	Overweight	Hold
Oct 30, 2024	Barclays	Equal-Weight	Equal-Weight	Hold
Oct 22, 2024	H.C. Wainwright	Buy	Buy	Hold
Oct 09, 2024	EF Hutton	-	Buy	Initialise
Sep 27, 2024	Scotiabank	Outperform	Outperform	Hold
Sep 27, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 27, 2024	Scotiabank	Sector Outperform	Sector Outperform	Hold
Sep 27, 2024	H.C. Wainwright	Buy	Buy	Hold
Sep 27, 2024	Barclays	Equal-Weight	Equal-Weight	Hold
Sep 26, 2024	Rodman & Renshaw	Neutral	Buy	Upgrade

Row per page

Go to

Biomea Fusion's last stock rating was published by Piper Sandler on Oct 31, 2024. The company gave BMEA a "Overweight" rating, the same as its previous rate.

Biomea Fusion Financial Forecast

Biomea Fusion Revenue Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Biomea Fusion's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. BMEA's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Biomea Fusion EBITDA Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict BMEA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Biomea Fusion's previous annual EBITDA (undefined) of $NaN.

Biomea Fusion Net Income Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-14.29M	$-12.89M	$-11.97M	$-7.35M	$-8.13M	$-7.33M	$-6.81M	$-7.18M	$-7.98M	$-7.19M	$-6.68M	$-7.04M	$-34.79M	$-33.05M	$-30.10M	$-29.30M	$-33.18M	$-34.21M	$-38.81M
High Forecast	$-14.29M	$-12.89M	$-11.97M	$-7.35M	$-8.13M	$-7.33M	$-6.81M	$-7.18M	$-7.98M	$-7.19M	$-6.68M	$-7.04M	$-34.79M	$-33.05M	$-30.10M	$-24.57M	$-28.54M	$-34.21M	$-38.81M
Low Forecast	$-14.29M	$-12.89M	$-11.97M	$-7.35M	$-8.13M	$-7.33M	$-6.81M	$-7.18M	$-7.98M	$-7.19M	$-6.68M	$-7.04M	$-34.79M	$-33.05M	$-30.10M	$-34.02M	$-39.82M	$-34.21M	$-38.81M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Biomea Fusion's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BMEA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Biomea Fusion SG&A Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Biomea Fusion's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to BMEA last annual SG&A of $NaN (undefined).

Biomea Fusion EPS Forecast

	Dec 28	Sep 28	Jun 28	Mar 28	Dec 27	Sep 27	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$-0.39	$-0.36	$-0.33	$-0.20	$-0.22	$-0.20	$-0.19	$-0.20	$-0.22	$-0.20	$-0.18	$-0.19	$-0.96	$-0.91	$-0.83	$-0.81	$-0.92	$-0.94	$-1.08
High Forecast	$-0.39	$-0.36	$-0.33	$-0.20	$-0.22	$-0.20	$-0.19	$-0.20	$-0.22	$-0.20	$-0.18	$-0.19	$-0.96	$-0.91	$-0.83	$-0.68	$-0.79	$-0.94	$-1.08
Low Forecast	$-0.39	$-0.36	$-0.33	$-0.20	$-0.22	$-0.20	$-0.19	$-0.20	$-0.22	$-0.20	$-0.18	$-0.19	$-0.96	$-0.91	$-0.83	$-0.94	$-1.10	$-0.94	$-1.08
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Biomea Fusion's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BMEA previous annual EPS of $NaN (undefined).

Biomea Fusion Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
HOWL	Werewolf Therapeutics	$1.78	$12.00	574.16%	Buy
BMEA	Biomea Fusion	$6.38	$22.75	256.58%	Buy
CGEM	Cullinan Oncology	$12.22	$31.50	157.77%	Buy
DSGN	Design Therapeutics	$5.57	$9.67	73.61%	Buy
EWTX	Edgewise Therapeutics	$31.98	$45.00	40.71%	Buy
IKNA	Ikena Oncology	$1.73	$1.33	-23.12%	Buy

BMEA Forecast FAQ

Is Biomea Fusion a good buy?

Yes, according to 8 Wall Street analysts, Biomea Fusion (BMEA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 87.50% of BMEA's total ratings.

What is BMEA's price target?

Biomea Fusion (BMEA) average price target is $22.75 with a range of $11 to $40, implying a 256.58% from its last price of $6.38. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Biomea Fusion stock go up soon?

According to Wall Street analysts' prediction for BMEA stock, the company can go up by 256.58% (from the last price of $6.38 to the average price target of $22.75), up by 526.96% based on the highest stock price target, and up by 72.41% based on the lowest stock price target.

Can Biomea Fusion stock reach $10?

BMEA's average twelve months analyst stock price target of $22.75 supports the claim that Biomea Fusion can reach $10 in the near future.

What is Biomea Fusion's current price target trend?

3 Wall Street analysts forecast a $23.33 price target for Biomea Fusion (BMEA) this month, up 265.67% from its last price of $6.38. Compared to the last 3 and 12 months, the average price target increased by 213.48% and increased by 171.00%, respectively.

What are Biomea Fusion's analysts' financial forecasts?

Biomea Fusion's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-29.455M (high $-29.455M, low $-29.455M), average SG&A $0 (high $0, low $0), and average EPS is $-0.813 (high $-0.813, low $-0.813). BMEA's analysts financial forecasts for the fiscal year (Dec 2028) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-46.504M (high $-46.504M, low $-46.504M), average SG&A $0 (high $0, low $0), and average EPS is $-1.284 (high $-1.284, low $-1.284).